Rxdx Clinics

Rxdx Clinics company information, Employees & Contact Information

Explore related pages

Related company profiles:

RxDx is a Bengaluru-based NABH and NABL-accredited multispeciality healthcare chain equipped with a pharmacy, radiology, and state-of-the-art lab. We are the primary healthcare centre in your neighbourhood taking care of your family from a range of health concerns like acute infections to chronic lifestyle ailments. Aside from doctors consulting on over 50 specialties, over 25 health check-up packages, home healthcare services like sample collection, pharmacy drop-offs, physiotherapy at home, vaccinations, post-surgical wound care, we have facilities like CT scan, X-ray, Ultrasound, Dopplers, TMT, Echo, and more.
Looking for a particular Rxdx Clinics employee's phone or email?

Rxdx Clinics Questions

News

Ventana TROP2 (EPR20043) RxDx Device Receives FDA Breakthrough Device Designation for Dato-DXd Selection in NSCLC - OncLive

Ventana TROP2 (EPR20043) RxDx Device Receives FDA Breakthrough Device Designation for Dato-DXd Selection in NSCLC OncLive

Roche receives FDA approval for the VENTANA MET (SP44) RxDx - GlobeNewswire

Roche receives FDA approval for the VENTANA MET (SP44) RxDx GlobeNewswire

Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC - Cure Today

Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC Cure Today

IASLC Highlights FDA Approval of VENTANA MET (SP44) RxDx Assay for NSCLC - Oncodaily

IASLC Highlights FDA Approval of VENTANA MET (SP44) RxDx Assay for NSCLC Oncodaily

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE - PR Newswire

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE PR Newswire

RxDx Clinics opens 10th flagship centre at Rajarajeshwari Nagar in Bengaluru - Express Healthcare

RxDx Clinics opens 10th flagship centre at Rajarajeshwari Nagar in Bengaluru Express Healthcare

RxDx Clinics opens 10th Flagship Multispecialty Centre in Bengaluru - IndiaMedToday

RxDx Clinics opens 10th Flagship Multispecialty Centre in Bengaluru IndiaMedToday

Merck’s Deal for Prometheus Expected to Generate Billions in Additional Sales - Barron's

Merck’s Deal for Prometheus Expected to Generate Billions in Additional Sales Barron's

Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck - Nasdaq

Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck Nasdaq

Roche Secures CE Mark for New CDx - Medical Device and Diagnostic industry

Roche Secures CE Mark for New CDx Medical Device and Diagnostic industry

Merck Acquires Prometheus Biosciences for $10.8 Billion - Investopedia

Merck Acquires Prometheus Biosciences for $10.8 Billion Investopedia

Roche buys Ignyta: RXDX-105 is to be discontinued, says source - Pharmaceutical Technology

Roche buys Ignyta: RXDX-105 is to be discontinued, says source Pharmaceutical Technology

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY - BioSpace

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY BioSpace

Matthew Bresnahan - Wilson Sonsini

Matthew Bresnahan Wilson Sonsini

FDA Approves VENTANA MMR RxDx To Identify dMMR Solid Tumors and as Companion Diagnostic for pMMR Endometrial Cancer - OncLive

FDA Approves VENTANA MMR RxDx To Identify dMMR Solid Tumors and as Companion Diagnostic for pMMR Endometrial Cancer OncLive

Merck close to deal for Prometheus Biosciences (MRK) - Seeking Alpha

Merck close to deal for Prometheus Biosciences (MRK) Seeking Alpha

Why Is Prometheus Biosciences (RXDX) Stock Up 175% Today? - InvestorPlace

Why Is Prometheus Biosciences (RXDX) Stock Up 175% Today? InvestorPlace

GSK Joins Biotech Buyout Spree With A $2 Billion Takeover - Investor's Business Daily

GSK Joins Biotech Buyout Spree With A $2 Billion Takeover Investor's Business Daily

Bayer To Set Up 27 Telemedicine Centres Across 8 States in the country - PR Newswire

Bayer To Set Up 27 Telemedicine Centres Across 8 States in the country PR Newswire

Mitra RxDx Announces $40 Million Financing Round - PR Newswire

Mitra RxDx Announces $40 Million Financing Round PR Newswire

Roche splashes $1.7B in cash for Ignyta and entrectinib - Fierce Biotech

Roche splashes $1.7B in cash for Ignyta and entrectinib Fierce Biotech

RxDx Healthcare receives NABL accreditation - Indian Pharma Post

RxDx Healthcare receives NABL accreditation Indian Pharma Post

RxDx Healthcare's Central Laboratory gets NABL Accreditation - Business Standard

RxDx Healthcare's Central Laboratory gets NABL Accreditation Business Standard

RxDx Healthcare launches seventh multispeciality clinic in North Bengaluru - UNITED NEWS OF INDIA

RxDx Healthcare launches seventh multispeciality clinic in North Bengaluru UNITED NEWS OF INDIA

RXDX identifies women's health as priority - BioSpectrum India

RXDX identifies women's health as priority BioSpectrum India

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant